DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Motzer RJ, Escudier B, McDermott DF. et al.
Nivolumab versus everolimus in advanced renal-cell carcinoma (Checkmate 025).
N Engl J Med 2015;
373: 1803-1813
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.